Literature DB >> 24168975

Unrecognized pediatric adult-type tuberculosis puts school contacts at risk.

Anna Steppacher1, Ianina Scheer, Christa Relly, Bea Začek, Alexander Turk, Ekkehardt Altpeter, Christoph Berger, David Nadal.   

Abstract

Adolescents with an immigrant background who are from tuberculosis high-incidence regions were at highest risk to develop adult-type tuberculosis disease in a low-incidence region during a 20-year period. If diagnosis and treatment were delayed up to 6 months, latent tuberculosis infection was detected in almost half of the affected individuals' school contacts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24168975     DOI: 10.1097/INF.0000000000000091

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Open flanks in the management of tuberculosis in Germany under the pressure of migration.

Authors:  Josef A I Weigl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-17       Impact factor: 3.267

Review 2.  Tuberculosis in Adolescents and Young Adults: Emerging Data on TB Transmission and Prevention among Vulnerable Young People.

Authors:  Katherine M Laycock; Leslie A Enane; Andrew P Steenhoff
Journal:  Trop Med Infect Dis       Date:  2021-08-05

3.  Tuberculosis in schools: an outbreak in northeastern Italy and some key health protection interventions.

Authors:  Luca Cegolon; Giuseppe Mastrangelo; Davide Gentili; Mario Mastromarino; Andrea Cegolon; Giuseppe Pichierri; Sandro Cinquetti; Saverio Bellizzi; Giovanni Sotgiu
Journal:  Croat Med J       Date:  2021-02-28       Impact factor: 1.351

4.  School and household tuberculosis contact investigations in Swaziland: Active TB case finding in a high HIV/TB burden setting.

Authors:  Piluca Alonzo Ustero; Alexander W Kay; Katherine Ngo; Rachel Golin; Bhekisisa Tsabedze; Bulisile Mzileni; Jessica Glickman; Mildred Wisile Xaba; Gcinile Mavimbela; Anna Maria Mandalakas
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.